A Dengue Vaccine

Cell. 2016 Jun 30;166(1):1. doi: 10.1016/j.cell.2016.06.036.


Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and has the potential to prevent hundreds of thousands of hospitalizations each year.

MeSH terms

  • DNA, Recombinant / administration & dosage
  • DNA, Recombinant / immunology
  • Dengue / immunology
  • Dengue / prevention & control*
  • Dengue Vaccines / administration & dosage*
  • Dengue Vaccines / immunology
  • Humans


  • DNA, Recombinant
  • Dengue Vaccines